Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![DermTimesNow Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::55642575.png) Dermatology Times [@DermTimesNow](/creator/twitter/DermTimesNow) on x 31.8K followers
Created: 2025-07-20 19:24:08 UTC

📖 A new meta-analysis confirms #abrocitinib significantly improves itch and lesion severity in moderate to severe atopic dermatitis, with a dose-dependent response and manageable safety profile.

 #DermTwitter #AD #AtopicDerm


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947014682063053309/c:line.svg)

**Related Topics**
[dermatology](/topic/dermatology)

[Post Link](https://x.com/DermTimesNow/status/1947014682063053309)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

DermTimesNow Avatar Dermatology Times @DermTimesNow on x 31.8K followers Created: 2025-07-20 19:24:08 UTC

📖 A new meta-analysis confirms #abrocitinib significantly improves itch and lesion severity in moderate to severe atopic dermatitis, with a dose-dependent response and manageable safety profile.

#DermTwitter #AD #AtopicDerm

XXX engagements

Engagements Line Chart

Related Topics dermatology

Post Link

post/tweet::1947014682063053309
/post/tweet::1947014682063053309